Literature DB >> 16364385

Rubella seroprevalence among first-grade primary school students in a district in Istanbul, Turkey.

P Ay1, A Topuzoglu, G Korukluoglu, S Cali.   

Abstract

OBJECTIVES: Rubella vaccination is not included in the national immunization programme of Turkey. However, it is on the market and is recommended, mainly by the private sector, at the age of 12-15 months. Introduction of the rubella vaccine without achieving high coverage has the risk of shifting the mean age of rubella infection among the unvaccinated population to reproductive ages. The aim of this study was to evaluate the seroprevalance of rubella and the factors associated with seropositivity among primary school students in Umraniye, a district of Istanbul.
METHODS: Blood samples were collected from 489 students in 70 primary schools of Umraniye. Parents completed a concise questionnaire assessing sociodemographic characteristics and measles, mumps and rubella vaccination status.
RESULTS: Among the students screened, 163 (33.3%, 95% confidence intervals 29.2-37.7%) were susceptible to rubella. When sociodemographic variables were evaluated, paternal education was the only variable associated with seronegativity. As the level of paternal education increased, seronegativity rates decreased. This finding may suggest that rubella vaccination is practiced more commonly among children whose fathers are better educated.
CONCLUSIONS: Surveillance and control of rubella and congenital rubella syndrome must be set as public health priorities in Turkey, particularly given that rubella vaccination is practiced partially in the country.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16364385     DOI: 10.1016/j.puhe.2005.09.006

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  2 in total

1.  Vaccination coverage and reasons for non-vaccination in a district of Istanbul.

Authors:  Sebahat D Torun; Nadi Bakirci
Journal:  BMC Public Health       Date:  2006-05-05       Impact factor: 3.295

2.  [Seroprevalence of rubella in Colombia: a birth-year cohort analysis].

Authors:  Doracelly Hincapie-Palacio; Viviana Lenis Ballesteros; Martha Ospina Ospina; Olga Lucía Pérez Toro; Francisco J Díaz
Journal:  Rev Saude Publica       Date:  2013-12       Impact factor: 2.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.